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The  potential  of  ultrahigh-performance  liquid  chromatography–mass  spectrometry  (UHPLC/MS)  and
ultrahigh-performance  supercritical  fluid  chromatography  (UHPSFC)  coupled  to  negative-ion  electro-
spray ionization  mass spectrometry  (ESI–MS)  for the  analysis  of  46  oxylipins  and  2  fatty  acid  standards
is  compared  in terms  of their  chromatographic  resolution  with  the  emphasis  on  distinguishing  isobaric
interferences  and  the  method  sensitivity.  UHPLC  provides  the  baseline  separation  of  24 isobaric  oxylipins
within  13 min,  while  UHPSFC  enables  the separation  of  only  20 isobaric  oxylipins  within  8 min.  More-
over,  the  UHPLC/ESI–MS  method  provides  an  average  improvement  of sensitivity  by 3.5-fold.  A  similar
trend  is observed  in  the  analysis  of human  plasma  samples,  but lower  ion  suppression  effects  causedrostaglandin
lasma
HPSFC/MS
HPLC/MS
PE
by  lysophospholipids  (LPL)  are  observed  in  case  of  UHPSFC/ESI–MS  due  to  better  separation  of LPL. Both
methods  are  fully  applicable  for the  analysis  of oxylipins,  but UHPLC/ESI–MS  method  is preferred  due
to  better  separation  and  higher  sensitivity,  which  results  in the  identification  of  31  oxylipins  in  human
plasma  based  on  available  standards  and  additional  tentative  20 identifications  based  on  accurate  m/z
values  and  the  fragmentation  behavior  known  from  the literature.SI
. Introduction
Oxylipins, including eicosanoids, docosanoids, and octade-
anoids, are an important family of lipids, which are formed by
he oxidation of polyunsaturated fatty acids (PUFA) [1]. They are
erived mainly from arachidonic acid (AA), docosahexaenoic acid,
icosapentaenoic acid and dihomo--linolenic acid. PUFAs are
ostly generated from glycerophospholipids (PL) by the enzyme
hospholipase A2, and then they are further metabolized to
icosanoids through enzymatic processes by free separate enzyme
amilies, such as cyclooxygenase (COX), lipoxygenase (LOX), and
ytochrome P450 (CYP). In addition, PUFA can be autooxidized
orming bioactive lipids via nonenzymatic pathways as well [1,2].
n humans, eicosanoids have a wide range of physiological effects in
nflammation, cardiovascular protection, blood clotting, and apo-
tosis. The important biological roles and excretion of these lipid
ediators into body fluids, such as blood, urine, and cerebrospinal
∗ Corresponding author.
E-mail address: Michal.Holcapek@upce.cz (M.  Holčapek).
ttp://dx.doi.org/10.1016/j.chroma.2017.06.070
021-9673/© 2017 Elsevier B.V. All rights reserved.©  2017  Elsevier  B.V.  All  rights  reserved.
fluid, make them potential biomarker targets [2–6]. However, the
concentration of eicosanoids (pmol/mL range) in human plasma
is much lower compared to other endogenous lipids (nmol/mL
range), such as glycerolipids, PL, sphingolipids, ceramides, and
sterols.Therefore their analysis requires more sensitive analytical
methods [7].
In past decades, the analysis of oxylipins was mainly per-
formed by immunoassay techniques, such as radioimmunoassays
(RIA) and enzyme immunoassays (EIA). The main disadvantage
of these methods is the limited applicability for plasma and tis-
sue samples due to immunological cross-reactivity and decreased
sensitivity due to protein – eicosanoid interactions [2]. Gas
chromatography–mass spectrometry (GC/MS) provides higher sen-
sitivity and better selectivity than RIA and EIA, but the essential
derivatization step during the sample preparation is time consum-
ing and laborious [8,9]. Nowadays, liquid chromatography–mass
spectrometry (LC/MS) is the most common technique used to
simultaneously analyze eicosanoids and other oxylipins, especially
in targeted tandem mass spectrometry (LC/MS/MS) mode using
triple quadrupole (QqQ) instruments with the selected reaction
monitoring (SRM) scanning mode [8], because it provides accu-
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ate quantitative information due to high sensitivity and selectivity
ithout derivatization step and the opportunity of online sam-
le extraction [9]. Mass spectrometry plays a major role in the
dentification and quantitation of eicosanoids. Negative-ion elec-
rospray ionization (ESI) is the most sensitive ionization mode for
icosanoids due to the presence of carboxylic acid [10]. The com-
rehensive nontargeted analysis of eicosanoids using quadrupole
ime-of-flight (QTOF) mass spectrometer provides more qualita-
ive information on analyzed samples, such as the identification
f new compounds, information on matrix or other endogenous
ompounds, while SRM scans on QqQ are better for sensitive quan-
itation [8–10].
The LC separation is the most widespread technique for the
nalysis of wide range of oxylipins. Reversed-phase (RP) mode per-
ormed mainly on octadecylsilica (C18) or octylsilica (C8) column
rovides the highest selectivity for the resolution of isobaric oxylip-
ns [2,6,8,9,11,12,14–18]. Oxylipins are determined in various body
uids, such as amniotic fluid, cerebrospinal fluid, urine, serum,
nd plasma [9,11–18]. LC/MS/MS method has been applied for
he simultaneous determination of 32 oxylipins in human plasma
amples in 29 min  using C8 column and ammonium formate – ace-
onitrile gradient [12]. Vreeken and coworkers have detected 36
uman plasma oxylipins in 26 min  by UHPLC/MS/MS method using
18 column and aqueous acetic acid – 2-propanol – acetonitrile
radient [16]. Recently, UHPLC/MS/MS method has been used to
dentify and quantify 60 endogenous oxylipins in human plasma
sing C18 column in 5 min  using aqueous acetic acid – acetonitrile
 2-propanol gradient [17]. Faccioli and coworkers have profiled
2 oxylipins in human plasma within 30 min  with UHPLC/MS/MS
ethod using C18 column and aqueous acetic acid – acetonitrile –
-propanol gradient [18].
Supercritical fluid chromatography (SFC) successfully combines
dvantages of gas and liquid chromatography, and especially the
ovel approach based on the use of sub–2 m particle columns
ields ultrafast and efficient separations. This technique is referred
s UHPSFC by the analogy to UHPLC, and may  be easily cou-
led to mass spectrometry as well (UHPSFC/MS) [19]. Applications
or various compounds classes illustrate the power of this new
pproach, e.g.,  example for synthetic cannabinoids [20], pharma-
eutical compounds [21], phospholipids, and sphingolipids [22].
owever, UHPSFC/MS method for the analysis of oxylipins has not
een reported so far.
The main goal of this study is a comparison of UHPLC/ESI–MS
nd UHPSFC/ESI–MS methods in terms of their suitability for the
nalysis of wide range of oxylipins in human plasma samples using
he set of 46 standards typically occurring in biological systems. All
arameters are carefully optimized to achieve the best selectivity
nd sensitivity of the final method, which is then applied for the
nalysis of endogenous oxylipins in the human plasma extract.
. Experimental
.1. Chemicals and standards
Methanol, acetonitrile, 2-propanol, ethanol (all LC/MS grade),
hloroform stabilized by 0.5–1% ethanol (HPLC grade), ammonium
ormate, ammonium acetate, formic acid, and acetic acid were pur-
hased from Sigma-Aldrich (St. Louis, MO,  USA). Deionized water
as prepared with a Milli-Q Reference Water Purification System
Molsheim, France). Carbon dioxide 4.5 grade (99.995%) was pur-
hased from Messer Group Gmbh (Bad Soden, Germany).8R-hydroxy-4Z,6E,10Z-hexadecatrienoic acid (tetranor-
2-HETE), 12S-hydroxy-5Z,8E,10E-heptadecatrienoic acid
12-HHTrE), 13-oxo-9Z,11E-octadecadienoic acid (13-
xoODE), 9-oxo-10E,12Z-octadecadienoic acid (9-OxoODE),. A 1511 (2017) 107–121
13S-hydroxy-9Z,11E,15Z-octadecatrienoic acid (13-HOTrE),
(±)13-hydroxy-9Z,11E-octadecadienoic acid (13-HODE),
(±)9-hydroxy-10E,12Z-octadecadienoic acid (9-HODE),
(±)12,13-dihydroxy-9Z-octadecenoic acid (12,13-DiHOME),
(±)15-hydroxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid (15-
HEPE), (±)5-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid
(5-HEPE), (±)11,(12)-epoxy-5Z,8Z,14Z-eicosatrienoic acid (11,12-
EET), (±)5,6-epoxy-8Z,11Z,14Z-eicosatrienoic acid (5,6-EET),
(±)12-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid (12-HETE),
(±)15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid (15-HETE),
(±)11-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoic acid (11-HETE),
(±)5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-HETE),
15S-hydroxy-8Z,11Z,13E-eicosatrienoic acid (15-HETrE),  9S-
hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic acid
(tetranor-PGDM), 9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic
acid (PGA2), 11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic
acid (PGJ2), 9S-hydroxy-11-oxo-5Z,12E,14E-prostatrienoic
acid (15-deoxy--12,14-PGD2), 15S-hydroxy-9-oxo-
5Z,8(12),13E-prostatrienoic acid (PGB2), (±)5,6-dihydroxy-
8Z,11Z,14Z,17Z-eicosatetraenoic acid (5,6-DiHETE),
5S,15S-dihydroxy-6E,8Z,10Z,13E-eicosatetraenoic acid (5,15-
DiHETE), 8S,15S-dihydroxy-5Z,9E,11Z,13E-eicosatetraenoic acid
(8,15-DiHETE), 5S,12R-dihydroxy-6Z,8E,10E,14Z-eicosatetraenoic
acid (LTB4), 5S,12R-dihydroxy-6E,8E,10E,14Z-eicosatetraenoic
acid (6-trans LTB4), (±)14,15-dihydroxy-
5Z,8Z,11Z-eicosatrienoic acid (14,15-DiHETrE),
(±)5,6-dihydroxy-8Z,11Z,14Z-eicosatrienoic acid (5,6-DiHETrE),
6-oxo-9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic
acid, sodium salt (2,3-dinor-6-keto-PGF1), 14S-hydroxy-
4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoic acid (14-HDoHE),
(±)4-hydroxy-5E,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid (4-
HDoHE), 9S,15S-dihydroxy-11-oxo-5Z,13E,17Z-prostatrienoic
acid (PGD3), 9,15-dioxo-11R-hydroxy-5Z-prostenoic
acid (13,14-dihydro-15-keto-PGE2), 9S,11R-epidioxy-
15S-hydroxy-5Z,13E-prostadienoic acid (PGH2),
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid
(PGE2), 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid
(PGD2), 9S,11R-dihydroxy-15-oxo-5Z,13E-prostadienoic
acid (15-keto-PGF2), 9S,11S-dihydroxy-15-oxo-
5Z-prostenoic acid (13,14-dihydro-15-keto-PGF2),
9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid
(PGF2), 9S,11R,15S-trihydroxy-5Z,13E-prostadienoic
acid-cyclo[8S,12R] (8-iso-PGF2), (±)19,20-dihydroxy-
4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid (19,20-DiHDPE),
9,11,15S-trihydroxythromba-5Z,13E-dien-1-oic acid (TXB2), 6-
oxo-9S,11R,15S-trihydroxy-13E-prostenoic acid (6-keto-PGF1),
7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic
acid (resolvin D1), and 5S-hydroxy,6R-(S-
cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid (LTE4) standards
(see Table S1 for structures) were purchased from Cay-
man  Chemical (Ann Arbor, MI,  USA). Fatty acid standards
6Z,9Z,12Z-octadecatrienoic acid (-linolenic acid), and
9Z,12Z,15Z-octadecatrienoic acid (-linolenic acid) were
purchased from Nu-Chek-Prep (Elysian, MN,  USA).
The oxylipins nomenclature and abbreviations follow the LIPID
MAPS structure database system [23]. Human plasma samples were
obtained from healthy volunteers based on the ethical agreement.
2.2. Sample preparation
The stock solution containing 46 eicosanoid and 2 fatty acid
standards at the concentration of 500 pg/L except for tetranor-
PGDM (2500 pg/L), 2,3-dinor-6-keto-PGF1 (2500 pg/L), PGD3
(2500 pg/L), 5,6-EET (1000 pg/L), PGH2 (2500 pg/L), and LTE4
(5000 pg/L) was prepared in ethanol. For UHPLC measurements,
the stock solution was dried under nitrogen at ambient tem-
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R. Berkecz et al. / J. Chrom
erature and redissolved in acetonitrile – water – acetic acid
45/55/0.02, v/v) mixture to prepare suitable concentration. In case
f UHPSFC analysis, working solutions were prepared in chloroform
 ethanol (50/50, v/v) mixture.
The solid phase extraction (SPE) was performed according to
he method described by Schebb et al. [24] with minor modifica-
ions. Aliquots of 500 L control plasma were diluted with 1.5 mL
0% aqueous methanol and vortexed for 10 s. Then the plasma
olution was centrifuged (Hettich
®
EBA 20 centrifuge EBA 20) at
000 rpm for 10 min  at ambient temperature. The oxylipins were
xtracted using StrataTM-X 33 m (200 mg/3 mL)  polymeric RP car-
ridges (8B-S100-FBJ-T, Phenomenex, Aschaffenburg, Germany).
artridges were conditioned with 3 mL  of methanol and then with
 mL  of water. Next, 2 mL  of samples were loaded on cartridges,
ith a subsequent wash using 3 mL  of water. Then oxylipins were
luted with 3 mL  of methanol. The eluent was dried under nitrogen
t ambient temperature and redissolved in 50 L of the eluent A
acetonitrile – water – acetic acid (45/55/0.02, v/v/v) mixture) for
HPLC or 50 L chloroform – ethanol (50/50, v/v) mixture in case
f UHPSFC measurements. Finally, the solution was  centrifuged at
000 rpm for 1 min  prior to transferring into 300 L conical insert.
.3. UHPLC/MS and UHPSFC/MS conditions
UHPLC/MS analyses were performed on a liquid chromatograph
gilent 1290 Infinity series (Agilent Technologies, Waldbronn,
ermany) consisting of an Agilent 1290 Infinity LC binary pump, an
gilent 1290 Infinity well plate autosampler and an Agilent 1290
nfinity column thermostat. The UHPLC system was coupled to the
aters Synapt G2-Si quadrupole – ion mobility – time of flight mass
pectrometer with ESI (Waters, Milford, MA,  USA).
The final UHPLC/MS method for the analysis of oxylipins was
s follows: Acquity UPLC BEH C18 column (150 × 2.1 mm,  1.7 m,
30 Å, Waters), injection volume 1 L, and column temperature
0 ◦C. The mobile phase A consisted of acetonitrile – water –
cetic acid (45/55/0.02, v/v/v) mixture, and the eluent B was  2-
ropanol – acetonitrile (50/50, v/v) mixture. The gradient program
as the following: 0 min  – 2% B, 12 min  – 62% B, 12.1 min  – 99% B,
4.5 min  – 99% B, 15 min  – 2% B, and 20 min  – 2% B. The flow rate
as 0.4 mL/min during the analysis (from 0 to 13.5 min) and the
quilibration before the next injection (from 18.5 to 20 min), and
.65 mL/min during the column washing after the analysis (from
3.5 to 18.5 min). The injector needle was washed with strong (hex-
ne – 2-propanol – water (2:2:1, v/v/v) mixture) and weak solvents
A eluent) after each injection.
All UHPSFC/MS experiments were done on an Acquity UPC2
ystem (Waters, Milford, MA,  USA) equipped with a binary sol-
ent manager delivery pump, a sample manager maintained at
◦C, 10 L injection loop, a column oven, a backpressure regula-
or, and a Waters Model 515 pump for delivering make-up solvent.
he chromatographic system was coupled to the mass spectrome-
er via dedicated interface kit (Waters) composed of two  T-pieces
nabling the backpressure control, and mixing of column effluent
ith a make-up solvent.
The following UHPSFC columns with the same column dimen-
ion (100 × 3 mm,  1.7 m)  were tested, i.e., Acquity UPC2 Torus
-Aminoanthracene (1-AA), Acquity UPC2 Torus 2-Piycolylamine
2-PIC), Acquity UPC2 Torus Diol (1-DIOL), Acquity UPC2 Torus
iethylamine (DEA), and Acquity UPC2 HSS C18 SB (1.8 m)  (HSS
18).
The final UHPSFC method for the analysis of oxylipins was
s follows: Acquity UPC2 Torus 1-Aminoanthracene (1-AA) col-
mn  (100 × 3 mm,  1.7 m,  Waters), active backpressure regulator
ABPR) pressure 1800 psi (124 bar), flow rate 1.7 mL/min, injection
olume 1 L, and column temperature 50 ◦C. The modifier 0.1%
cetic acid in methanol was used as the eluent B. The gradient pro-. A 1511 (2017) 107–121 109
gram was the following: 0 min  – 4% B, 10 min – 30% B, 11 min  –
30% B, 11.5 min  – 4% B, and 15 min  – 4% B. The injector needle was
washed with hexane – 2-propanol – water (2:2:1, v/v/v) mixture
after each injection. Pure methanol was delivered as a make-up
eluent at the flow rate of 0.3 mL/min.
The mass spectrometer was operated in the negative-ion ESI
sensitivity mode under the following conditions: mass range of m/z
50–950, capillary voltage 2.2 kV, source temperature 150 ◦C, sam-
pling cone 20 V, source offset 90 V, drying temperature 500 ◦C, cone
gas flow rate 50 L/h, desolvation gas flow rate 1000 L/h, and neb-
ulizer gas pressure 4 bar. Leucine enkephaline was used as a lock
mass for all experiments. The data dependent acquisition (DDA)
experiments were performed on a transfer cell with the collision
energy ramp from 17 to 40 eV with the selection of up to 3 ions.
The setting of mass spectrometer was identical for both UHPLC/MS
and UHPSFC/MS measurements except for decreased desolvation
gas flow rate (800 L/h) used for UHPSFC/MS analysis in order to
achieve the stable spray.
2.4. Data processing
The UHPLC system was controlled with Agilent OpenLAB soft-
ware. The control of UHPSFC system, MS  data acquisition and
processing were conducted by MassLynx V4.1 SCN 901 and inte-
grated TargetLynx softwares. Calculations were performed using
Microsoft Excel software.
3. Results and discussion
A set of 46 oxylipin standards representing 36 eicosanoids, 4
docosanoids, 6 octadecanoids, and 2 fatty acids (see Table S1 for
the complete list and structures) was used for the optimization of
UHPLC/MS and UHPSFC/MS conditions. The previous occurrence of
these standards in human plasma was an important aspect during
their selection based on published works [7,12,16–18]. Chromato-
graphic and mass spectrometric parameters were optimized to
improve the separation and sensitivity. The final UHPLC/MS and
UHPSFC/MS methods were compared, and the former one was
applied for profiling of human plasma oxylipins. The MS  sensitivity
and chromatographic resolution were the main aspects during the
optimization due to low natural abundances of oxylipins.
3.1. Optimization of UHPLC/MS method
3.1.1. Column selection and initial conditions
The Acquity UPLC BEH C18 column was  selected for the RP anal-
ysis of oxylipins based on the literature [14,17,25]. The coelution
of oxylipin isomers makes their identification and quantification
complicated, therefore longer column (150 mm)  was  selected to
improve the isomeric separation. The starting conditions were
based on the mobile phase consisted of eluent A acetonitrile –
water – acetic acid (60/40/0.02, v/v/v), eluent B 2-propanol – ace-
tonitrile (50/50, v/v), and the gradient program from 0 min – 0.1%
B to 6 min  – 55.5% B, but too low retention was observed for
tetranor-PGDM, 2,3-dinor-6-keto-PGF1, PGD3,  8-iso-PGF2,
PGF2, 6-keto-PGF1, PGE2, PGH2,  and TXB2 (retention factors
lower than 1.2). Therefore, the amount of water in the eluent A was
increased to 55% water to improve their retention. In parallel, the
gradient program was  also changed (0 min  – 0.1% B, 6 min – 70.0% B,
6.75 min  – 99.0% B, 7.50 min  – 99% B, 7.65 min – 0.1% B, and 15 min
– 0.1%B).3.1.2. Effect of mobile phase composition
Effects of additives in the eluent A on the retention behavior and
MS sensitivity of oxylipins were studied for the following addi-
tives: acetic acid (0.02 and 0.05%), formic acid (0.02 and 0.05%),
110 R. Berkecz et al. / J. Chromatogr. A 1511 (2017) 107–121
Fig. 1. Effect of additives in acetonitrile – water (45/55, v/v) mobile phases on negative-ion UHPLC/ESI–MS extracted ion chromatograms of the standard mixture of isomeric
H ) 5 mM ammonium formate, (C) 0.05% formic acid, (D) 0.02% formic acid, (E) 0.05% acetic
a opanol – acetonitrile (50/50, v/v), Acquity UPLC BEH C18 column (2.1 × 150 mm,  1.7 m,
1 ram 0 min  – 0.1% B, 6 min  – 70.0% B, and 6.75 min – 99.0% B.
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Fig. 2. Dependencies of peak areas of oxylipins standards in negative-ion
UHPLC/ESI–MS on the composition of eluent A containing various additives in com-
parison to conditions without any additives: (A) 5 mM ammonium acetate, (B) 5 mMETE/EET for the different composition of eluent A: (A) 5 mM ammonium acetate, (B
cid,  (F) 0.02% acetic acid, and (G) without any additive. Conditions: eluent B – 2-pr
30  Å, Waters), flow rate 0.5 mL/min, column temperature 40 ◦C, and gradient prog
 mM ammonium acetate, and 5 mM ammonium formate (Fig. 1).
he lowest retention was observed with ammonium acetate, while
cetic and formic acids resulted in the highest retention times at
.05%. The use of acetic and formic acids at the same concentration
0.02% or 0.05%) resulted in different pH values of the mobile phase,
ut the retention and resolution of isomers did not change signifi-
antly. For all compounds, higher retention times were observed
or higher acid content (0.05%). The comparison of chromato-
raphic resolution for isomers obtained with and without additives
how that higher resolution was achieved with acetic acid, formic
cid and without any additive, except for -linolenic acid, -
inolenic acid, 15-HETE, 11-HETE, 12-HETE, 5-HETE, 11,12-EET,
,15-DiHETE, 6-trans LTB4, 14-HDHA,  and 4-HDHA, where the
obile phases with ammonium acetate provided better results.
eak shapes were not influenced considerably by additives. The
erious peak tailing was observed for LTE4 in the absence of any
dditive and in ammonium acetate or ammonium formate con-
aining mobile phases. The peak shape was improved at higher acid
oncentrations, which can be explained by suppressed zwitterion
ormation of cysteinyl side chain (isoelectric point at pH 5.07) in
ore acidic environment [26]. The oxalic acid treatment of sta-
ionary phase using the injection of 20 L of 10 mM oxalic acid two
imes [27] had also a substantial effect on the improvement of peak
hape of LTE4.
Fig. 2 demonstrates the dependence of negative-ion ESI
esponse on the type and concentration of additives. Acetic acid
ammonium formate, (C) 0.05% formic acid, (D) 0.02% formic acid, (E) 0.05% acetic
acid, and (F) 0.02% acetic acid. Other conditions are identical as for Fig. 1.
R. Berkecz et al. / J. Chromatogr
Table  1
Average relative changes in UHPLC for retention times (tR), peak widths, peak
areas, and resolution (Rs) for increased flow rates of 0.4 and 0.5 mL/min in compar-
ison to the initial value of 0.3 mL/min.
Flow rate [mL/min] tR peak width peak area Rs
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Five UHPSFC columns with the same column dimension
F
a
a
a
0.4 −33% −21% −31% −6%
0.5  −54% −33% −51% −14%
nhanced the ionization compared to the mobile phase without
ny additive (ca. 90% on the average for 0.02% and 40% for 0.05% of
cetic acid). The use of formic acid caused the signal suppression
ca. 15% for 0.02% and 45% for 0.05% of formic acid). The addition of
mmonium acetate or formate resulted in the drastic loss of sen-
itivity. 0.02% of acetic acid was selected as optimal for the further
ptimization of other parameters.
The retention and selectivity of the separation can be tuned by
he composition of the organic solvent B. Four types of eluents B
ere investigated, such as 2-propanol – acetonitrile (50/50, v/v),
-propanol – acetonitrile (10/90, v/v), acetonitrile, and methanol.
he concentration of 2-propanol exhibited only a slight effect on
etention, resolution, and sensitivity. The highest retention was
bserved for methanol, but it negatively influenced the separation,
specially in case of -linolenic acid, -linolenic acid, 13-HODE,
-HODE, and all HETE. Finally, 2-propanol – acetonitrile (50/50, v/v)
as selected, because this was the most efficient in the removal
f plasma phospholipid contaminants (in spite of SPE sample
ig. 3. Effect of the flow rate on negative-ion UHPLC/ESI–MS extracted ion chromatogr
dditive in the eluent A: (A) 0.5 mL/min, (B) 0.4 mL/min, and (C) 0.3 mL/min. Gradient pr
nd  6.75 min  – 99.0% B, (B) 0 min  – 0.1% B, 7.52 min  – 70.0% B, and 8.44 min  – 99.0% B, and
re  identical as for Fig. 1.. A 1511 (2017) 107–121 111
treatment) from the column during the washing step of gradient
program.
3.1.3. Effect of flow rate
The increased flow rate reduces the analysis time, but on the
other hand it also influences the resolution and sensitivity. Fig. 3
demonstrates the effect of flow rate in the range of 0.3–0.5 mL/min
for isomers 15-HETE, 11-HETE, 12-HETE, 5-HETE, 11,12-EET,  and
5,6-EET. Gradients for different flow rates are recalculated based on
the ratio of squared column internal diameters. Average retention
times and peak widths were decreased for all compounds, when
the flow rate increased (Table 1), but it also reduced peak areas.
The moderate reduction of resolution was  observed with increased
flow rates for isomers. 0.4 mL/min is chosen in the final method
as a compromise among the short analysis time, high selectivity,
and ESI response. The oxylipin and fatty acid standards eluted in
the range of 1–12 min  (Fig. 4 and Table 2). The flow rate gradient
program was used during the washing and equilibration cycle to
reduce the total run time.
3.2. Development of UHPSFC/MS method
3.2.1. Column selection(100 × 3 mm,  1.7 m)  and different chemistries were used in
our column screening, i.e.,  1-AA, 2-PIC, 1-DIOL, DEA, and HSS
C18, in order to find the optimal stationary phase for the anal-
ams of the standard mixture of isomeric HETE/EET using 0.02% acetic acid as the
ograms are adjusted for individual flow rates: (A) 0 min  – 0.1% B, 6 min  – 70.0% B,
 (C) 0 min  – 0.1% B, 10.02 min – 70.0% B, and 11.25 min  – 99.0% B. Other conditions
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Table 2
Chromatographic and mass spectrometric data for oxylipin and fatty acid standards in the final UHPLC/MS method.
Abbreviation Subclass Isomeric group Theoretical m/z  of [M−H]− tR in UHPLC/MS [min] RS Indentified in plasma
tetranor-PGDM Prostaglandins – 327.1449 0.96 No
6-keto-PGF1 Prostaglandins 1  369.2283 1.24 1.25 No
TXB2  Thromboxanes 1.53 Yes
8-iso-PGF2 Prostaglandins 2 353.2334 1.52 1.53 Yes
PGF2 1.73 4.96 Yes
13,14-dihydro-15-keto-PGF2  2.43 No
2,3-dinor-6-keto-PGF1 Prostaglandins – 341.1970 1.71 No
PGD3  Prostaglandins – 349.2021 1.71 No
PGH2 Prostaglandins 3  351.2177 1.88 No
PGE2  1.88 1.34 Yes
15-keto-PGF2 2.03  0.68 No
PGD2  2.08 3.35 Yes
13,14-dihydro-15-keto-PGE2 2.48 No
Resolvin  D1 Docosanoids – 375.2177 2.37 No
PGA2 Prostaglandins 4 333.2071 3.15 0.96 No
PGJ2  3.33 No
PGB2  3.33 7.51 Yes
15-deoxy--12,14-PGD2 4.51 No
8,15-DiHETE Hydroxy/hydroperoxyeicosatetraenoic
acids
5 335.2228 3.85 2.15 Yes
5,15-DiHETE 4.14 0.71 Yes
6-trans  LTB4 Leukotrienes 4.22 1.55 Yes
LTB4  4.48 6.33 No
5,6-DiHETE Hydroxy/hydroperoxyeicosatetraenoic acids 5.54 Yes
12,13-DiHOME Other octadecanoids – 313.2384 4.75 Yes
19,20-DiHDPE Docosanoids – 361.2384 5.33 Yes
tetranor-12-HETE Hydroxy fatty acids – 265.1809 5.34 No
14,15-DiHETrE Hydroxy/hydroperoxyeicosatrienoic
acids
6 337.2384 5.40 8.46 Yes
5,6-DiHETrE 7.18 Yes
12-HHTrE  Hydroxy/hydroperoxyeicosatrienoic acids – 279.1966 5.50 Yes
LTE4  Leukotrienes – 438.2320 5.60 No
13-HOTrE Other  octadecanoids 7 293.2122 6.34 7.77 Yes
13-OxoODE 7.83 1.72 Yes
9-OxoODE 8.22 Yes
15-HEPE  Hydroxy/hydroperoxyeicosapentaenoic acids 8 317.2122 6.70 4.94 Yes
5-HEPE  acids 7.55 Yes
13-HODE Other  octadecanoids 9 295.2279 7.56 1.10 Yes
9-HODE  7.73 Yes
15-HETE Hydroxy/hydroperoxyeicosatetraenoic
acids
10 319.2279 7.85 2.23 Yes
11-HETE  8.26 1.20 Yes
12-HETE  8.48 3.39 Yes
5-HETE  9.13 3.05 Yes
11,12-EET Epoxyeicosatrienoic
acids
9.72 2.32 No
5,6-EET  10.16 No
14-HDoHE Docosanoids 11  343.2279 8.17 6.26 Yes
4-HDoHE  9.34 Yes
15-HETrE  Hydroxy/hydroperoxyeicosatrienoic acids – 321.2435 8.68 Yes
-Linolenic  acids Unsaturated fatty acids 12 277.2173 11.70 0.91 Yes
-Linolenic  acids 11.90 Yes
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ig. 4. Negative-ion UHPLC/ESI–MS extracted ion chromatograms of standard mixtu
30  Å, Waters), flow rate 0.4 mL/min, column temperature 40 ◦C, eluent A acetonitri
nd  gradient program 0 min – 2% B, 12 min  – 62% B, and 12.1 min  – 99% B. Details a
sis of oxylipins. The following parameters were chosen for
he initial optimization: eluent B 10 mM ammonium acetate in
ethanol, methanol as the make-up eluent, ABPR pressure 1800 psi
124.1 bar), flow rate 1.0 mL/min, injection volume 1 L, column
emperature 50 ◦C, and the gradient program 0 min  – 1% B, 5 min
 50% B, 12 min  – 50% B, and 13 min  – 1% B. First, the reten-
ion behavior of selected standards representing different types
f isomerism was studied (PGA2, 15-deoxy--12,14-PGD2, PGB2,
GD2, PGE2, PGF2, 8-iso-PGF2, TXB2, and 6-keto-PGF1).  For
ll compounds, the lowest retention was observed on HSS C18 col-
mn  compared with other stationary phases, moreover PGF2,
-iso-PGF2, PGD2, and PGE2 are not separated. The obtained low
etention and poor selectivity indicated the importance of elec-
rostatic attraction between the carboxylate group from analytes
nd the basic functionality in the stationary phase, which is not
ccurring at all or only with mild effects on HSS C18 stationary
hase due to the lack of additional ionizable functional groups
eside residual silanols (pKa = 7–8) [28,29]. DEA had the most basic
unctionality (calculated basic pKa = 9.5), providing strong electro-
tatic interactions with deprotonated carboxyl groups of oxylipins,
hus resulting in the highest retention times for all analytes, and
enerally accompanied by highest peak width, which resulted in
he lower resolution. HSS C18 and DEA columns were excluded
rom further optimization based on above mentioned observations.
omparable retention and selectivity were observed on the remain-
ng three stationary phases, therefore those were further tested.
-DIOL provided lower retention of oxylipins compared to the basicained using final conditions: Acquity UPLC BEH C18 column (2.1 × 150 mm,  1.7 m,
ater – acetic acid (45/55/0.02, v/v/v), eluent B 2-propanol – acetonitrile (50/50, v/v),
he Experimental.
stationary phases. Lower retention times were observed for all ana-
lytes on 1-AA relative to 2-PIC column [29]. Fig. 5 demonstrated
that 1-AA stationary phase provided a superior chromatographic
resolution for 11,12-EET, 12-HETE, 15-HETE, 11-HETE, and 5-
HETE isomers over 1-DIOL and 2-PIC columns. For -linolenic acid
and -linolenic acid, the partial separation was  obtained only on
1-AA stationary phase. The bulky anthracene ring may  improve
the recognition process of isomers in at least two  ways, such as
the formation of additional hydrophobic interactions and steric
hindrance. Finally, 1-AA column was selected for the develop-
ment of UHPSFC/MS method considering the chromatographic data
obtained for HETE, which exhibit numerous biologically important
isomers in plasma.
3.2.2. Effect of flow rate
One of the main benefits of UHPSFC is the feasibility of using
high flow rate [30,19], therefore 1.0, 1.5, 1.7, 2.0, and 2.3 mL/min
flow rates were tested. The increased the flow rate from 1.0 mL/min
resulted in the following average reductions of retention times: 36%
at 1.5 mL/min, 44% at 1.7 mL/min, 53% at 2.0 mL/min, and 60% at
2.3 mL/min. The average resolution of isomers changed only mod-
erately, and the maximum was  found at 1.5 mL/min. The resolution
was only slightly lower at 1.7 mL/min. The increase of the flow
rate from 1.5 to 1.7 mL/min decreased peak widths, especially for
tetranor-PGDM eluting at the beginning. The decrease of observed
peak areas was very small (only 3%). Therefore, 1.7 mL/min was
used in the final method.
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-Aminoanthracene (1-AA), (B) Acquity UPC2 Torus 2-Pycolylamine (2-PIC), and (C)
 mL/min, column temperature 50 ◦C, modifier 10 mM ammonium acetate, gradien
The effect of flow rate of make-up eluent on the sensitivity
as also studied, and the trend of average signal reduction with
ncreasing flow rate from 0.15 mL/min was the following: 10% at
.2 mL/min, 13% at 0.25 mL/min and 20% at 0.30 mL/min. Despite
he lower sensitivity at higher flow rate, 0.30 mL/min is essential
o achieve stable spray in ESI–MS, especially at the beginning of
nalysis with low modifier content.
.2.3. Effect of temperature and backpressure
The selectivity and mainly the retention in UHPSFC can be influ-
nced by the density of mobile phase through the regulation of
emperature and backpressure [31]. In order to study the effect
f temperature on the chromatographic behavior of oxylipins, 40,
0, and 60 ◦C were selected at 124 bar backpressure. For all com-
ounds, higher retention times are observed at higher temperature,
hile the separation of isomers was not influenced significantly.
he effect of temperature on the change of retention was reduced
y increasing the content of organic modifier in the mobile phase
uring the gradient program (Fig. S1). The distribution of data
orrelates with graphs obtained for diffusion coefficients of antho-
yanins dependence on the methanol content in the mobile phase
32]. This retention behavior might be explained by decreased
iffusion coefficients of oxylipins with increased organic solvent
ontent and probably by the transition from supercritical to sub-
ritical state in the range of 12–16% methanol [32,33]. The similar
hromatographic behavior was found with decreased backpres-
ure from 138 to 103 bar. The column temperature of 50 ◦C and
he backpressure of 124 bar were selected in the final method.atograms of the standard mixture of isomeric HETE/EET: (A) Acquity UPC2 Torus
ity UPC2 Torus Diol (1-DIOL) columns. Conditions: ABPR pressure 124 bar, flow rate
ram 0 min  – 1% B, 10 min  – 50% B, and make-up pump flow rate 0.2 mL/min.
3.2.4. Effect of gradient steepness
The retention and selectivity in UHPSFC can be influenced by
the gradient steepness similarly as for other chromatographic tech-
niques [31]. 30% of organic modifier provides sufficient elution
strength even for the elution of more retained polar standards,
for example tetranor-PGDM and 2,3-dinor-6-keto-PGF1. Thus,
the range from 4% to 30% of the eluent B was  used for the ini-
tial optimization step. In order to investigate the effect of gradient
steepness on the chromatographic retention, a study was carried
out with the gradient slope of 2.6, 5.2, and 10.4% of B/min. Retention
times increased with decreased gradient steepness. This increase
was 36% at 5.2% of B/min and 86% at 2.6% of B/min on the aver-
age. For the separation of isomers, a similar trend was  found in
the increase of resolution (57% and 152%) with the decrease of the
gradient steepness.
3.2.5. Selection of organic co-solvent and mobile phase additives
The polarity of supercritical carbon dioxide is similar to hex-
ane, thus the use of polar organic modifier in the mobile phase is
essential for the elution of more polar compounds [19]. Methanol
is the most common organic modifier in UHPSFC owing to its phys-
ical and chemical properties, such as its high elution strength, and
the complete miscibility with supercritical fluid carbon dioxide
at given temperature and pressure ranges. Moreover, the mobile
phase additives (e.g., ammonium acetate or formate) are well sol-
uble in methanol at typically used concentrations [31]. Methanol
with 10 mM of ammonium acetate was  used as the organic modi-
fier in the initial stage of optimization. The effect of other organic
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ig. 6. Effect of different additives in methanol as a modifier on negative-ion UHPS
A)  10 mM ammonium acetate, (B) 10 mM ammonium formate, (C) 0.02% formic ac
ressure 124 bar, flow rate 1.7 mL/min, column temperature 50 ◦C, gradient program
odifiers in methanol was tested for 10% or 20% of acetonitrile
r 2-propanol in methanol. For all compounds, the addition of
ither acetonitrile or 2-propanol increased the retention moder-
tely, while no influence on the separation of isomers was detected,
herefore only methanol is used in further optimization steps.
The application of polar additives, such as acid, base, neutral salt
r buffer in the mobile phase can influence the retention, selectiv-
ty and sensitivity through different ways depending on properties
mainly acid – base) of analyte, types of packed stationary phase and
he detection mode [29,19,31]. Considering basic properties of 1-AA
olumn and the detection of acidic oxylipins by negative-ion mode
SI–MS, the effects of acetic acid, formic acid, ammonium acetate,
nd ammonium formate on the chromatographic behavior and the
ensitivity were investigated and compared with the mobile phase
ithout any additive. The nature of additives showed only mod-
rate effects on the retention, while the sensitivity was  influenced
onsiderably. Fig. 6 reveals that the use of different mobile phase
dditives for 1,12-EET, 12-HETE, 15-HETE, 11-HETE, and 5-HETE
somers, slightly lower retention was observed for formic acid,
hile higher retention times were obtained when using salts, espe-
ially with ammonium acetate. Generally, increased retention and
lightly improved resolution were obtained for increased concen-
ration of ammonium acetate (1, 5, 10, 20, and 30 mM).  However,
he increase of acetic acid content (0.01, 0.02, 0.05, 0.1, and 0.2%) did
ot influence the retention and selectivity. The effect of additives
n peak shape was negligible.
The concentration of acetic acid in the range of 0–0.2% does
ot show any visible effect on the retention. Fig. 6 shows the roleI–MS extracted ion chromatograms of the standard mixture of isomeric HETE/EET:
) 0.02% acetic acid, and (E) without any additives. Conditions: 1-AA column, ABPR
in  – 4% B, 10 min  – 30% B, and make-up pump flow rate 0.25 mL/min of methanol.
of additives in the MS  response. The use of ammonium acetate
provided the lowest responses, as general trend for all com-
pounds (47%), while the highest peak areas were obtained without
any additives (i.e., 100%) in methanol. Slightly higher response
was found for ammonium formate (61%). The reduction of signal
was more considerable for increased concentration of ammonium
acetate, for example the mean intensity was reduced to approx-
imately 50% with the change of concentration from 1 to 30 mM.
Acetic acid (96%) provided a better sensitivity than formic acid
(85%). The mean peak area showed a maximum at 0.1% of acetic
acid within the tested range from 0 to 0.2%. The use of buffers in
the mobile phase slightly improved the separation of isomers, but
on the other hand it resulted in a serious loss of sensitivity, therefore
0.1% acetic acid was  selected as the mobile phase additive.
The effect of water content (1, 2, and 5%) in the mobile phase
containing 0.1% acetic acid on the retention and selectivity was
studied. A slight improvement of peak shapes was achieved with
5% of water, but the ESI response was  dramatically reduced by 65%.
The similar signal reduction was  observed for 1% water in methanol
used as a make-up solvent, therefore water was not used either in
the mobile phase or make-up solvent in further experiments.
3.2.6. Effect of sample solvent and injected volume
The type of solvent and injected volume can influence the peakshape and the retention time as well. Hexane and heptane are
the best choice for dissolution solvent due to the similar polar-
ity with supercritical carbon dioxide [19]. Hexane and chloroform
were selected as commonly used nonpolar solvents in lipidomics.
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ig. 7. Negative-ion UHPSFC/ESI–MS extracted ion chromatograms of the standa
ethanol, ABPR pressure 124 bar, flow rate 1.7 mL/min, column temperature 50 ◦C, 
f  methanol. Details are in the Experimental.
owever, the addition of polar organic solvent into chloroform was
ecessary for more polar standards. Thus, the effect of methanol
nd ethanol content and type of nonpolar solvents was investigated
n chromatographic results. No significant changes were observed
or retention times. The use of hexane and chloroform with 50%
thanol content showed that chloroform resulted in narrower peak
idths. Concerning contribution of polar organic solvent (50%) in
hloroform, the addition of ethanol resulted in better peak shape
han methanol, additionally better separation occurred in case of
ow retained linolenic acid isomers. Interestingly, higher chloro-
orm content did not provide any improvement in peak shapes.
he selection of chloroform – ethanol (50/50, v/v) was the best
ompromise considering peak profiles, proper polarity, and low
olatility. The injected volume may  have the main effect on the
eak distortion [19], therefore measurements were carried out for
he injection volumes of 1, 2, 3, and 5 L. The increase of injection
olume resulted in no change in the retention, but it decreased the
hromatographic resolution, as expected. This trend was  more evi-
ent for less retained compounds. Thus, the injected volume was
imited to 1 L.
The final UHPSFC/MS method provided baseline separation for
0 oxylipin standards within 7 min  (Fig. 7 and Table 3)..3. Comparison of UHPLC/MS and UHPSFC/MS
Fig. 8 demonstrated different retention mechanisms with a
ow degree of orthogonality (r2 = 0.8) between UHPLC/MS andxture obtained using final conditions: 1-AA column, modifier 0.1% acetic acid in
nt program 0 min  – 4% B, 10 min  – 30% B, and make-up pump flow rate 0.30 mL/min
UHPSFC/MS methods. Generally, the increase of the compound
hydrophobicity resulted in higher retention in RP-UHPLC, while the
opposite trend was observed in UHPSFC. A different elution order
between UHPLC and UHPSFC was observed for isomeric groups 1, 2,
3, 4, 5, 7, 10,  and 12.  For -linolenic acid, -linolenic acid, 11,12-
EET, and 5,6-EET, the highest retention was  observed in UHPLC,
while lowest retention times were obtained in UHPSFC. Resolvin
D1,  2,3-dinor-6-keto-PGF1, TXB2, and 6-keto-PGF1 with 3
hydroxyl groups provided highest retention times in UHPSFC. For
TXB2, broad (in UHPSFC) and tailing (in UHPLC) elution profiles may
be associated with the interconversion between hemiacetal iso-
mers [34]. The presence of additional carboxyl group in more polar
analyte tetranor-PGDM caused the tailing peak with increased
retention in UHPSFC. The contribution of polar cysteinyl side chain
of LTE4 may  contribute to the peak shape distortion. This unfa-
vorable effect was  more pronounced in UHPSFC, where it disabled
the detection of LTE4 due to extremely tailing peaks. The degree
of unsaturation also influenced the retention, mainly in UHPLC.
Table 2 reveals that for 15-HETrE,  15-HETE, and 15-HEPE, the
reduction in retention times correlates with the increase in the
number of double bonds.
Tables 2 and 3 show that UHPLC generally provides better
separation of isomers than UHPSFC method except for positional
isomeric groups of 2, 4, 5, and 9. Higher retention and resolu-
tion were observed for positional isomers PGJ2, PGA2, and PGB2
in UHPSFC. It indicates that the position of the carbonyl group at C9
was more favorable for dipole–dipole interaction than at C11, thus
R
.
 Berkecz
 et
 al.
 /
 J.
 Chrom
atogr.
 A
 1511
 (2017)
 107–121
 
117
Table 3
Chromatographic and mass spectrometric data for oxylipin and fatty acid standards in the final UHPSFC/MS method.
Abbreviation Subclass Isomeric group Theoretical m/z of [M−H]− tR in UHPSFC/MS [min] RS Indentified in plasma
tetranor-PGDM Prostaglandins – 327.1449 7.03 No
TXB2  Thromboxanes 1 369.2283 5.36 1.02 Yes
6-keto-PGF1  Prostaglandins 5.86 No
13,14-dihydro-15-keto-PGF2 Prostaglandins 2  353.2333 4.37 7.23 No
PGF2  5.41 1.75 Yes
8-iso-PGF2  5.66 Yes
2,3-dinor-6-keto-PGF1  Prostaglandins – 341.1970 5.90 No
PGD3  Prostaglandins – 349.2021 4.82 No
13,14-dihydro-15-keto-PGE2 Prostaglandins 3  351.2177 4.03 4.81 No
PGH2  4.71 No
PGE2  4.71 0.68 Yes
PGD2  4.77 0.78 Yes
15-keto-PGF2a 4.83 No
Resolvin  D1 Docosanoids – 375.2177 6.30 No
PGJ2 Prostaglandins 4  333.2071 3.61 1.02 No
PGA2  3.73 3.07 No
15-deoxy--12,14-PGD2 4.08 2.10 No
PGB2  4.28 Yes
5,6-DiHETE Hydroxy/hydroperoxyeicosatetraenoic
acids
5 335.2228 3.91  9.12 Yes
5,15-DiHETE 4.60 0.73 Yes
8,15-DiHETE 4.67 2.40 Yes
LTB4 Leukotrienes 5.02 1.32 No
6-trans  LTB4 5.22 Yes
12,13-DiHOME Other octadecanoids – 313.2384 3.47 Yes
19,20-DiHDPE Docosanoids – 361.2384 3.86 Yes
tetranor-12-HETE Hydroxy fatty acids – 265.1809 2.78 No
14,15-DiHETrE Hydroxy/hydroperoxyeicosatrienoic
acids
6  337.2384 3.37 2.60 Yes
5,6-DiHETrE 3.82 Yes
12-HHTrE Hydroxy/hydroperoxyeicosatrienoic acids – 279.1966 2.87 Yes
LTE4  Leukotrienes – 438.2320 n.d. No
13-OxoODE Other  octadecanoids 7 293.2122 2.10 0.44 Yes
9-OxoODE 2.13 6.29 Yes
13-HOTrE  2.72 Yes
15-HEPE Hydroxy/hydroperoxyeicosapentaenoic
acids
8  317.2122 2.69 4.09 Yes
5-HEPE  3.23 Yes
13-HODE Other  octadecanoids 9 295.2279 2.68 1.48 Yes
9-HODE  2.85 Yes
11,12-EET Epoxyeicosatrienoic
acids
10  319.2279 1.70 1.09 No
5,6-EET  1.84 6.18 No
12-HETE Hydroxy/hydroperoxyeicosatetraenoic
acids
2.54 0.96 Yes
15-HETE  2.64 0.90 Yes
11-HETE  2.75 2.76 Yes
5-HETE  3.14 Yes
14-HDoHE Docosanoids 11  343.2279 2.90 3.78 Yes
4-HDoHE  3.43 Yes
15-HETrE  Hydroxy/hydroperoxyeicosatrienoic acids – 321.2435 2.78 Yes
-Linolenic acids Unsaturated fatty acids 12 277.2173 1.27 0.42 Yes
-Linolenic  acids 1.30 Yes
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Fig. 8. Correlation of retention times in UHPLC/ESI–
osition of double bond in the cyclopentane ring had higher con-
ribution to the separation of isomers. For diastereoisomers PGF2
nd 8-iso-PGF2 and functional isomers of 15-keto-PGF2 and
GF2, higher retention was observed in UHPSFC, and this was
ccompanied by higher resolution.
The sensitivity of given analytical method was also an important
spect due to low concentrations of oxylipins in biological samples.
pproximately 3.5-fold higher sensitivity on average was observed
n UHPLC/MS in comparison to UHPSFC/MS. Figs. 4 and 7 with the
ame scale of intensity illustrate the different sensitivity in both
ethods. In UHPSFC, the signal reduction could be attributed to the
ollowing reasons: 1/applied higher flow rate, 2/lower ionization
fficiency due to decreased sample solubility during carbon dioxide
xpansion, and 3/dilution and splitting of eluted sample prior to
S detection [35]. The lower concentration of compounds in the
ffluent might be caused by different diameters between UHPSFC
3 mm)  and UHPLC (2.1 mm)  columns [36].
.4. Identification of oxylipins in human plasma
The enrichment of oxylipins through polar and nonpolar matrix
emoval is a critical step prior to their analysis due to their trace
oncentration in biological samples. Nowadays, SPE is one of the
ost efficient and widespread technique in the sample preparation
rocedure. The polymeric StrataX RP column showed a good recov-
ry for oxylipins [7,17,24,37]. The application of relatively high
olume of plasma sample was needed due to the limited injection
olume in UHPSFC. Numerous glycerophospholipids (PL), mainly
yso species, enriched with oxylipins and fatty acids in the extracts,
aused matrix effects due to the coelution with oxylipins, which
luted in the range of 2–7 min  in UHPSFC and 1–10 min  in UHPLC
Tables 2 and 3). This unfavorable effect was more pronounced in
HPLC owing to comparable retention of oxylipins and LPLs in the
P separation. For example, high abundant LPI 20:4 and LPI 18:2,d UHPSFC/ESI–MS methods using final conditions.
coeluted with PGE2 and PGD2 at 2.1 min. Retention times of other
LPE and LPC were found in the range of 8–10 min, e.g., LPE 18:2,
LPE 22:6, LPC 16:0, and LPC 22:6, while in UHPSFC they eluted
after 9 min, which reduces the risk of ion suppression effects. Fatty
acids had higher retention times in UHPLC (after 9.5 min) and lower
retention in UHPSFC (before 2.3 min), therefore the risk of ion sup-
pression effects is relatively low in both cases.
Tables 2 and 3 show 31 oxylipins identified in human plasma
based on 48 standards by both methods. Considering better sepa-
ration of isomers and higher sensitivity, the optimized UHPLC/MS
method was selected for the identification of additional plasma
oxylipins. The further identification of additional oxylipins with-
out available authentic standards was  based on their retention
times, accurate masses of precursor ions (7 ppm mass toler-
ance at maximum), and related fragment ions using homemade
database created based on own  measurements and literature
sources [1–7,12,16–18,23,38,39]. Relevant chromatographic and
MS data of additional 20 possible compounds in plasma includ-
ing retention times, m/z of precursor ions, and observed fragment
ions corresponding to structures are given in Table 4.
4. Conclusions
Optimized UHPLC/ESI–MS and UHPSFC/ESI–MS methods have
been applied for the analysis of 46 oxylipins and 2 fatty acids stan-
dards. In UHPLC, mobile phase additives and their concentrations
significantly influence the chromatographic retention and MS  sen-
sitivity, especially the use of acetic acid brings advantages over
ammonium acetate or formate in terms of the resolution and sensi-
tivity. The UHPSFC/ESI–MS method for oxylipins is reported for the
first time here. 1-AA column yields a better separation of oxylipins
than other dedicated sub–2 m UHPSFC stationary phases (2-PIC,
1-DIOL, DEA, and HSS C18). The chromatographic resolution of
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Table 4
UHPLC/MS/MS data for tentatively identified oxylipins without given standards in the human plasma sample.
Name Abbreviation Subclass Experimental
m/z of
[M−H]−
Mass
accuracy
[ppm]
tR in
UHPLC/MS
[min]
m/z of observed fragment ions
5,9S,11R-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8S,12R] 5-iso-PGF2 VI Isoprostanes 353.2317 4.8 1.89 335, 317, 309, 115
9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid 11-PGE2 Prostaglandins 351.2164 3.7 1.95 333, 315, 271, 189
9,10-dihydroxy-12Z-octadecenoic acid 9,10-DiHOME Other octadecanoids 313.2371 4.2 5.14 295, 277, 201, 177
9-hydroxy-10E,12Z,15Z-octadecatrienoic acid 9-HOTrE 293.2106 5.5 6.20 275, 231, 185, 171, 121
(+/−)-11-hydroxy-5Z,8Z,12E,14Z,17Z-eicosapentaenoic acid 11-HEPE Hydroxy/hydroperoxyeicosapentaenoic acids 317.2115 2.2 6.28 299, 259, 255, 215, 195, 167,
149, 121
(+/−)-14(15)-epoxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid 14(15)-EpETE Other eicosanoids 317.2106 5.0 6.58 299, 255, 219, 207
(+/−)-20-hydroxy-4Z,7Z,10Z,13Z,16Z,18E-docosahexaenoic acid 20-HDoHE Docosanoids 343.2280 −0.3 7.51 325, 299, 285, 281, 241, 187,
159, 133, 107
(+/−)-17-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid 17-HDoHE 343.2276 0.9 8.02 325, 281, 273, 245, 229, 227,
201, 173, 147, 121, 111
15-oxo-5Z,8Z,11Z,13E-eicosatetraenoic acid 15-oxo-ETE Hydroxy/hydroperoxyeicosatetraenoic acids 317.2107 4.7 8.05 299, 273, 139, 113
(+/−)-9,10-epoxy-12Z-octadecenoic acid 9(10)-EpOME Other octadecanoids 295.2271 2.7 8.20 277, 183, 201, 171
(+/−)-10-hydroxy-4Z,7Z,11E,13Z,16Z,19Z-docosahexaenoic acid 10-HDoHE Docosanoids 343.2278 0.3 8.22 325, 299, 281, 227, 181, 161,
153, 121
(+/−)-11-hydroxy-4Z,7Z,9E,13Z,16Z,19Z-docosahexaenoic acid 11-HDoHE 343.2277 0.6 8.41 325, 281, 227, 194, 165, 149,
133, 121, 95
8-hydroxy-5Z,9E,11Z,14Z-eicosatetraenoic acid 8-HETE Hydroxy/hydroperoxyeicosatetraenoic acids 319.2276 0.9 8.60 301, 257, 163, 155
(+/−)-7-hydroxy-4Z,8E,10Z,13Z,16Z,19Z-docosahexaenoic acid 7-HDoHE Docosanoids 343.2278 0.3 8.61 325, 281, 245, 227, 201, 147,
141, 121, 113, 97
(+/−)-8-hydroxy-4Z,6E,10Z,13Z,16Z,19Z-docosahexaenoic acid 8-HDoHE 343.2276 0.9 8.69 299, 281, 243, 189, 135, 109
9-hydroxy-5Z,7E,11Z,14Z-eicosatetraenoic acid 9-HETE Hydroxy/hydroperoxyeicosatetraenoic
acids
319.2272 2.2 8.77 301, 275, 257, 229, 203, 179,
167, 139, 123, 69
12-oxo-5Z,8Z,10E,14Z-eicosatetraenoic acid 12-oxo-ETE 317.2122 0.0 9.01 299, 273, 235, 153
(6E,8Z,11Z)-5-hydroxyicosa-6,8,11-trienoic acid 5-HETrE 321.2415 6.2 9.10 303, 259, 205, 115
(+/−)-12(13)-epoxy-9Z-octadecenoic acid 12(13)-EpOME Other octadecanoids 295.2275 1.4 9.20 277, 195, 183
5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid 5-oxo-ETE Hydroxy/hydroperoxyeicosatetraenoic acids 317.2102 6.3 9.63 299, 273, 245, 203, 129
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everal critical isomeric pairs in UHPSFC is lower compared to RP-
HPLC, which shows that RP-like mode in UHPSFC is not really
ompetitive to RP-UHPLC unlike to HILIC mode, where UHPSFC is
uperior to HILIC-UHPLC. This is probably caused by natural limi-
ations of UHPSFC, where the typical mobile phase is nonpolar CO2
ith the addition of some polar modifier, which is far from the typ-
cal RP mobile phases used in UHPLC. In general, the sensitivity
f UHPLC/MS is higher by a factor of ca. 3.5 times in compar-
son to UHPSFC/MS, but some opposite examples can be found
s well, e.g., prostaglandins. The sensitivity decrease is partially
aused by different column diameters (the ratio of squared inter-
al diameters is about 2). Finally, 31 oxylipins from 46 available
tandards are detected in the human plasma extract together with
dditional 20 tentatively identified endogenous oxylipins based on
HPLC/MS/MS measurements and home-made database of precur-
or and product ions and accurate m/z  values of measured ions.
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